Oliveira-Neto Helenisa Helena, Silva Erica Tatiane, Leles Cláudio Rodrigues, Mendonça Elismauro Francisco, Alencar Rita de Cássia, Silva Tarcília Aparecida, Batista Aline Carvalho
Department of Stomatology-Oral Pathology, Dental School, Federal University of Goiás, Goiânia, Brazil.
Tumour Biol. 2008;29(4):262-71. doi: 10.1159/000152944. Epub 2008 Sep 9.
The chemokine stromal cell-derived factor (SDF-1/CXCL12) and its specific receptor, CXCR4, have been implicated in the regulation of tumor growth and organ-specific spread. The aim of this study was to determine the expression of CXCL12 and CXCR4 in samples obtained from primary squamous cell carcinoma (SCC) of the oral cavity (OCSCC) and of the lip (LSCC) and in metastatic and non-metastatic lymph node tissues. The relationship of CXCL12/CXCR4 with clinical and microscopic parameters was also evaluated. The analysis of mRNA expression revealed a higher expression of CXCR4 in oral SCC compared with healthy oral mucosa (p = 0.006). The density of CXCR4+ cells was higher in parenchyma of OCSCC with lymph node metastases than in LSCC. With regard to the stroma, OCSCC showed a greater CXCR4+ and CXCL12+ cell percentage in relation to LSCC. Furthermore, the density of CXCL12+ and CXCR4+ nodal cells was higher in metastatic than non-metastatic lymph nodes in the same patients. Considering clinical and microscopic parameters, we found a positive association between the percentages of CXCL12+ and CXCR4+ stromal cells and the tumor proliferation index. Our findings suggest that the CXCL12/CXCR4 system may play a role in tumor cell spread to lymph nodes and also in neoplastic development.
趋化因子基质细胞衍生因子(SDF-1/CXCL12)及其特异性受体CXCR4与肿瘤生长及器官特异性转移的调控有关。本研究旨在确定从口腔原发性鳞状细胞癌(OCSCC)和唇部原发性鳞状细胞癌(LSCC)以及转移性和非转移性淋巴结组织中获取的样本中CXCL12和CXCR4的表达情况。同时评估了CXCL12/CXCR4与临床及微观参数之间的关系。mRNA表达分析显示,与健康口腔黏膜相比,口腔鳞状细胞癌中CXCR4的表达更高(p = 0.006)。有淋巴结转移的OCSCC实质中CXCR4+细胞的密度高于LSCC。关于基质,与LSCC相比,OCSCC中CXCR4+和CXCL12+细胞的百分比更高。此外,同一患者中,转移性淋巴结中CXCL12+和CXCR4+细胞的密度高于非转移性淋巴结。考虑临床和微观参数,我们发现CXCL12+和CXCR4+基质细胞的百分比与肿瘤增殖指数之间存在正相关。我们的研究结果表明,CXCL12/CXCR4系统可能在肿瘤细胞向淋巴结的转移以及肿瘤发生发展中发挥作用。